Video Document for Exam 1 Flashcards
What is meant by the column title “Activation”?
activation, a cluster of symptoms that represent a hyperarousal event characterized by impulsivity, restlessness, and/or insomnia.
Agoraphobic/panic treatment times.
assign the longer time (24 months) to agoraphobic and 18 to all other panic disorders.
Ramelteon (Rozerem) is confusing to me - so it is good for patients w/a hx of substance abuse, but it cannot be used in pts w/liver impairment, but aren’t those often times the same people? What do you do if you have a patient who has a hx of substance abuse and has impaired liver function? What would you prescribe for them?
It would also depend on the extent of liver disease, mild to moderate is likely to tolerate ramelteon with monitoring. Severe cases would be more likely to have issues.
For diarrhea, do you start an antibiotic when one symptom is bloody diarrhea?
No, but it is a red flag. Generally, if fever plus bloody diarrhea then yes or if going on for 3 days with worsening symptoms. If blood is bright red will need to determine if they suffer from hemorrhoids or anal fissures before jumping to conclusions too.
What about HRT and an intact uterus, I cannot remember
HRT should always include a progesterone component in women with an intact uterus to decrease the risk of endometrial cancer.
SSRIs and suicidality:
Monitor weekly in first few weeks in patient with comorbid depression and pts under age 25.
SSRIs and weight gain:
_________ is more likely to cause weight gain.
Paroxetine
SSRIs and thrombocytopenia:
Reported with ______________.
citalopram
SSRIs and QT prolongation.
Before starting ____________, consider EKG and measurement of QT interval in patients with cardiac disease.
citalopram
SSRIs and discontinuation syndrome:
Avoid disrupt discontinuation in all but ____________.
fluoxetine
SNRIs and elevated BP:
Monitor BP on initiation and regularly during treatment
TCAs and anticholinergic effects:
Contraindicated with narrow-angle glaucoma, BPH, and urinary retention
TCAs and sedation:
Administer at bedtime when feasible.
TCAs and cholinergic rebound:
Avoid abrupt discontinuation; taper doses.
BZDs and anterograde amnesia and memory impairment:
Risk of anterograde amnesia is worsened with concomitant intake of alcohol